These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3368132)

  • 21. Trends in psychotropic medication costs for children and adolescents, 1997-2000.
    Martin A; Leslie D
    Arch Pediatr Adolesc Med; 2003 Oct; 157(10):997-1004. PubMed ID: 14557161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When medicine becomes a disease.
    Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expenditure and consumption of medicines in Israel 1975-85: analysis of trends and elements of growth.
    Sax P
    Isr J Med Sci; 1988 Jun; 24(6):307-16. PubMed ID: 3136096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical management in ProCare Health Limited.
    Malcolm L; Barry M; MacLean I
    N Z Med J; 2001 Jun; 114(1134):283-6. PubMed ID: 11480510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
    Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
    Gross DJ; Schondelmeyer SW; Raetzman SO
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economics of drug prescribing in Ireland.
    O'Hanrahan M; O'Malley K
    Ir Med J; 1981 Oct; 74(10):309-10, 312. PubMed ID: 7309452
    [No Abstract]   [Full Text] [Related]  

  • 28. Attitudes of the public to medical care: part 6. Pharmaceutical benefits.
    Dixon CW; Dodge JS; Emery GM; Salmond GC; Spears GF
    N Z Med J; 1975 Jul; 82(544):45-8. PubMed ID: 809735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a monetary incentive on primary care prescribing in Ireland: changes in prescribing patterns in one health board 1990-1995.
    Walley T; Murphy M; Codd M; Johnston Z; Quirke T
    Pharmacoepidemiol Drug Saf; 2000 Dec; 9(7):591-8. PubMed ID: 11338918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs: towards sound prescribing and pricing.
    Mariko M
    World Health Forum; 1991; 12(1):34-7. PubMed ID: 1859595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an evidence report and policies lifting reimbursement restrictions for acid suppressants: analysis of the Belgian national database.
    van Driel ML; Vander Stichele R; Elseviers M; De Sutter A; De Maeseneer J; Christiaens T
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1113-22. PubMed ID: 18823069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Minimizing the costs of prescription of anti-infective drugs in two areas of primary health care].
    Castán Cameo S; García Latorre FJ; Martínez Gorostiaga J; Sierra Moros MJ; Solano Bernad VM; Peral Casado A
    Rev Esp Salud Publica; 1998; 72(1):33-42. PubMed ID: 9477714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
    Rudholm N
    Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of prescription pricing and a call for equitable payment.
    Grapes ZT; Brown TR
    Hospitals; 1976 Jul; 50(13):91-2, 96, 98. PubMed ID: 1278895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Containing medicines costs in the private sector--the example of a medical benefit scheme.
    Hukins G; Boyce D
    S Afr Med J; 1990 Aug; 78(3):152-4. PubMed ID: 2116045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The maximum medical aid price programme. A review of the concept and of its ability to reduce expenditure on medicines.
    Boyce D; Bartlett G
    S Afr Med J; 1990 Aug; 78(3):147-51. PubMed ID: 2116044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Price indexes for pharmaceuticals used by the elderly.
    Thomas J; Schondelmeyer S
    Health Care Financ Rev; 1992; 14(1):91-105. PubMed ID: 10124442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The right prescription for GPs?
    Ball D
    Practitioner; 1989 May; 233(1468):629. PubMed ID: 2513565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.